SkinnyRx vs SnagRx: Oral Tablets vs Price-Locked Compounds
SkinnyRx vs SnagRx compares two direct-pay telehealth options for compounded GLP-1 therapy. Quick verdict: choose SkinnyRx if you want daily oral semaglutide tablets with FSA/HSA eligibility and free overnight shipping; choose SnagRx if your priority is the lowest advertised annual-plan price and a price lock across titration.
Get SkinnyRx oral semaglutide from $249/mo
How these providers differ at a glance
Both deliver clinician-prescribed compounded GLP-1 medications via telehealth, but they target different priorities: SkinnyRx emphasizes oral semaglutide tablets, FSA/HSA use, and overnight shipping, while SnagRx emphasizes very low annual-plan pricing, a locked-in flat rate across dose changes, and named US 503A pharmacies with a clinician network.
Key difference 1: Medication format and product focus
SkinnyRx promotes daily oral semaglutide tablets taken sublingually as an alternative for people who prefer not to use injections. SnagRx offers compounded semaglutide and tirzepatide largely described as injections, with pricing shown for compounded injections and compounds available through partner pharmacies.
Why format matters
If you specifically want oral tablets, the source shows SkinnyRx provides daily semaglutide tablets. If you are shopping for low-cost compound injections and a tirzepatide option, SnagRx lists both semaglutide and tirzepatide injection pricing.
Key difference 2: Pricing model and commitments
SkinnyRx lists pricing as low as $249/mo. SnagRx advertises semaglutide from $69/mo and tirzepatide from $119/mo but clarifies those are 12-month plan rates; month-to-month equivalents are $99 and $149. SnagRx also emphasizes a price locked flat at every dose for life on the annual plan, avoiding re-pricing during titration.
See SnagRx pricing and 12-month plan options
Key difference 3: Financial flexibility and guarantees
SkinnyRx highlights FSA/HSA eligibility so patients can use pre-tax dollars. SnagRx highlights an outcome-related 6-month weight-loss guarantee and a full refund if a prescription is declined, subject to its posted terms. SnagRx also notes refund on declined prescriptions and a clinician review timeline.
Key difference 4: Pharmacy partners, clinician networks, and testing
SnagRx names its US 503A partner pharmacies and OpenLoop Health as its clinician network covering 48 states, and states clinician review typically within five hours with next-day shipping. SkinnyRx notes partner pharmacies perform third-party testing every 3 to 6 months and states prescriptions require an online consultation and clinician review.
Regulatory and safety notes both providers share
Both providers supply compounded medications. The sources explicitly state that compounded medications are not FDA-approved finished products and are not reviewed by the FDA for safety, effectiveness, or quality. Each provider recommends clinician oversight and telehealth assessment before a prescription is completed.
Comparison table
| Criteria | SkinnyRx | SnagRx |
|---|---|---|
| Starting price | As low as $249/mo | From $69/mo on 12-month plan; $99/mo month-to-month |
| Medication format | Daily oral semaglutide tablets | Compounded semaglutide and tirzepatide injections listed |
| Price structure | Monthly pricing shown; split payments with Affirm available | Price locked flat at every dose on annual plan; avoids re-pricing during titration |
| Shipping | Free overnight shipping on all orders; ships after prescription processing | Next-day UPS/FedEx delivery in temperature-controlled packaging |
| Pharmacies & clinician network | Partner pharmacies perform third-party testing every 3 to 6 months | Names US 503A partner pharmacies and OpenLoop Health clinicians; covers 48 states |
| Refunds and guarantees | Full refund if canceled before provider completes prescription review; subscription cancel anytime | Full refund if prescription declined; 6-month weight-loss guarantee terms apply |
Practical differences for patients
SnagRx is positioned for cost-driven patients willing to commit to a 12-month plan to access $69/mo semaglutide and a locked price through dose changes. SkinnyRx is positioned for patients who prioritize an oral tablet option, the ability to use FSA or HSA funds, and free overnight shipping.
Start SkinnyRx online consultation for oral semaglutide
Start SnagRx assessment and view pharmacy partners
Conclusion and final recommendation
Both providers offer clinician-prescribed compounded GLP-1 options but with different tradeoffs. SkinnyRx stands out for daily oral semaglutide tablets, explicit FSA/HSA eligibility, and free overnight shipping. SnagRx stands out for bottom-of-market annual-plan pricing, a price lock across titration, named 503A pharmacies, and an established clinician network.
Choose SkinnyRx if you want oral semaglutide tablets, FSA or HSA payment flexibility, and fast overnight delivery. Choose SnagRx if you want the lowest annual-plan price with a locked flat rate across dosing and named pharmacy and clinician partners.